A trial looking at improving chemotherapy for children with acute myeloid leukaemia (MyeChild01)

This trial is looking at using liposomal daunorubicin, mitoxantrone, fludarabine and cytarabine to improve chemotherapy for acute myeloid leukaemia. It is open to children and young people with:

• acute myeloid leukaemia (AML)

• high risk myelodysplastic syndrome (MDS)

• an isolated myeloid sarcoma (granulocytic sarcoma)

This summary is 1 of 3 summaries of the MyeChild01 trial. We have information on:

• dose finding study

• stem cell transplant

Cancer Research UK supports the MyeChild01 trial.

This study is for children and young people who haven’t reached their 18th birthday. We use the term ‘you’ in the summary but if you are a parent we are referring to your child.